A synthesized Khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. Developed to normalize retinal function and support eye health. Clinical studies in Russia report improved visual function in 95% of patients with various retinal pathologies.

Is Normoftal FDA approved?

No, Normoftal is not FDA approved. Current status: Approved in Russia - Clinical use for retinal support

What are the side effects of Normoftal?

Reported side effects of Normoftal include: Well-tolerated with no reported side effects, No allergic reactions in clinical studies, Individual intolerance to components (rare), Should not replace standard eye treatments.

What is the typical dosing for Normoftal?

Khavinson bioregulator dosing - clinically used in Russia. Common doses observed in research: Therapy: 20 mg twice daily (2 capsules x2), Prevention: 20 mg once daily (2 capsules). Duration: 30-day courses, repeat after 2-6 months. Administration: Oral capsules, before meals.

Cognitive

Normoftal

Also known as: Eye Peptide Bioregulator, Retina Peptide, AKS-G Peptide

Clinical Trials

Popular For

Eye health, retinal support, vision preservation

Key Facts: Normoftal

Category: Cognitive
FDA Status: Not FDA Approved
Clinical Status: Approved in Russia - Clinical use for retinal support
Administration: Oral capsules, before meals
Typical Dose: 2 capsules 1-2x daily
Frequency: 1-2x daily, before meals
Evidence Level: Human Trials
Duration: 30-day courses, repeat after 2-6 months

Also Known As

Eye Peptide Bioregulator, Retina Peptide, AKS-G Peptide

Mechanism of Action

Normoftal normalizes eye function by reducing peptide deficiency and restoring protein synthesis inside retinal cells. Contains peptide AKS-G (lysine, glutamic acid). May have neuroprotective effects on retinal neurons by modulating gene expression and protein synthesis, helping preserve the integrity and function of retinal nerve cells critical for transmitting visual information to the brain.

Research Summary

From 1995 to 2010, at the St. Petersburg Institute of Bioregulation and Gerontology, 1500 patients with retinal pathology were treated: 40.3% with macular degeneration, 30.3% with diabetic retinopathy, 23.0% with retinitis pigmentosa. Improved visual functions were reported in 95% of patients. Research suggests it may aid treatment of glaucoma, diabetic retinopathy, and age-related macular degeneration.

Clinical Status:Approved in Russia - Clinical use for retinal support

Trial Progress:Preclinical

Pre

III

FDA

Dosing Information

Human Trials·Clinical studies in Russia with 1500+ patients

Typical DosingⓘDoses commonly used by people in practice, based on community reports and anecdotal experience.

Community experience

Common Dose

2 capsules 1-2x daily

Range

2-4 capsules per day

Frequency

1-2x daily, before meals

Khavinson retinal bioregulator with extensive clinical use in Russia. Studies report 95% of patients with macular degeneration, diabetic retinopathy, or retinitis pigmentosa showed improved visual function. Often combined with Visoluten (natural retina peptide extract). May increase effectiveness of standard treatments for glaucoma and cataracts.

Research DosingⓘDoses from published scientific studies and clinical trials. May include human or animal research.

Scientific studies

Khavinson bioregulator dosing - clinically used in Russia

Doses from Studies

20-40 mg daily (therapy)

Russian Clinical Studies 1995-2010 - 1500 patients with retinal pathology - 95% improvement ↗

20 mg daily (prevention)

Khavinson Protocol - Prevention of age-related eye conditions ↗

Duration

30-day courses, repeat after 2-6 months

Administration

Oral capsules, before meals

Timing & Administration

Best Time to Take

Morning and evening, before meals

1-2 times daily depending on protocol

Food Recommendation

With or without food

Why This Timing?

Split dosing for therapeutic use. Prevention protocols use once daily dosing.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

●Well-tolerated with no reported side effects
●No allergic reactions in clinical studies
●Individual intolerance to components (rare)
●Should not replace standard eye treatments

References

https://khavinson.info/research/peptides-and-retina

Related Peptides

Peptides commonly compared with Normoftal or used in similar applications.

Selank

Clinical Trials

A synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects. Known for anxiolytic properties without sedation.

Cognitive

Semax

Clinical Trials

A synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Approved in Russia for stroke and cognitive enhancement. Known for nootropic and neuroprotective effects.

Cognitive

Cerebrolysin

Clinical Trials

A mixture of low-molecular-weight neuropeptides derived from pig brain. Approved in many countries for stroke, traumatic brain injury, and dementia.

Cognitive

Dihexa

Preclinical

A potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.

Cognitive

GB-115

Clinical Trials

A dipeptide anxiolytic and nootropic that acts as a CCK-1 (cholecystokinin) receptor antagonist. Developed in Russia with completed Phase 3 trials for anxiety. Users report significant improvements in focus, attention, and ADHD-like symptoms.

Cognitive

P21

Preclinical

A synthetic peptide mimetic of CNTF (ciliary neurotrophic factor) designed for neurodegenerative disease. Promotes neurogenesis and reduces neuroinflammation.

Cognitive

How to Use Normoftal Normoftal Alternatives Compare with Similar Browse All Peptides

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors

PRO

Want updates on Normoftal research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.

Back to all peptides